QQQ $ 612.07 nm (nm)
DIA $ 467.44 nm (nm)
SPY $ 672.02 nm (nm)
TLT $ 91.60 nm (nm)
GLD $ 401.10 $ 14.16 (3.64 %)
$ 6.31
$ 6.37
$ 6.33 x 87
$ 6.53 x 3
$ 6.25 - $ 6.46
$ 6.05 - $ 9.24
75,907
na
nm
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Auna Intends to Meet with Debt and Equity Investors to Assess Alternatives to Raise Funds to Expand its Operations in Mexico an...

Core News & Articles

Auna (NYSE:AUNA) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.13 by 153.85 pe...

Core News & Articles

Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in...

Core News & Articles

Auna (NYSE:AUNA) 

Core News & Articles
Preview: Auna's Earnings
05/19/2025 14:03:56

Core News & Articles
Auna Files Form 20-F For FY2024
04/10/2025 21:00:52

Core News & Articles

Auna (NYSE:AUNA) reported quarterly sales of $1.06 billion which missed the analyst consensus estimate of $1.10 billion by 2.98...

Core News & Articles

JP Morgan analyst Joseph Giordano maintains Auna (NYSE:AUNA) with a Overweight and raises the price target from $13 to $13.5.

Core News & Articles

Auna (NYSE:AUNA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.15 by 73.33 per...

Core News & Articles

JP Morgan analyst Joseph Giordano maintains Auna (NYSE:AUNA) with a Overweight and lowers the price target from $14 to $13.

Core News & Articles

Auna (NYSE:AUNA) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.13 by 76.92 p...

Core News & Articles

JP Morgan analyst Joseph Giordano maintains Auna (NYSE:AUNA) with a Overweight and lowers the price target from $16 to $14.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION